ClinicalTrials.Veeva

Menu

Alteration of Stool Microbiota in Preterm Infants With Anemia

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Dysbiosis
Anemia, Neonatal
Necrotizing Enterocolitis

Study type

Observational

Funder types

Other

Identifiers

NCT03554278
STU 092017-028

Details and patient eligibility

About

This study evaluates the relationship between anemia and stool microbiota in premature infants. It also evaluates the relationship between blood transfusion and stool microbiota.

Full description

Necrotizing enterocolitis (NEC) is a leading cause of death in preterm infants, yet the disease mechanism is not well understood. Among the factors that have been studied are the change in stool microbiota (dysbiosis), severe anemia, and transfusion. Studies suggest that dysbiosis occurs in neonates with NEC. Large studies and meta-analyses have shown a predominance of Gammaproteobacteria, a decrease in Firmicutes, and decreased bacterial diversity in stool from infants with NEC. Studies do not support a relationship between transfusions and NEC since there are conflicting findings on this topic. There is a suggestion, however, that severe anemia may be associated with NEC though this requires further study.

No studies have been done evaluating the relationship between anemia and change in stool microbiota, or blood transfusion and change in stool microbiota. This study aims to primarily evaluate the relationship between anemia and stool microbiota, and secondarily evaluate the relationship between transfusion and stool microbiota.

Enrollment

57 patients

Sex

All

Ages

7 to 30 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Preterm infants less than 32 weeks gestation at birth
  • Age at enrollment between 7 days and less than/equal to 30 days
  • Minimum 100 mL/kg/day enteral feeds

Exclusion criteria

  • Development of necrotizing enterocolitis (NEC) prior to enrollment
  • Prior surgery
  • Major congenital anomalies
  • Oxygen requirement with FiO2 (fraction of inspired oxygen) >50% (at time of enrollment)

Trial design

57 participants in 2 patient groups

Anemia
Description:
Stool samples from infants with anemia. Severe anemia defined as hematocrit less than 25%. Anemia defined as hematocrit greater than or equal to 25% and less than 30%.
No Anemia
Description:
Stool samples from infants without anemia. No anemia defined as hematocrit equal to or greater than 30%.

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems